NO975508L - DNA-sekvens og kodet bryst- spesifikt brystkreftprotein - Google Patents

DNA-sekvens og kodet bryst- spesifikt brystkreftprotein

Info

Publication number
NO975508L
NO975508L NO975508A NO975508A NO975508L NO 975508 L NO975508 L NO 975508L NO 975508 A NO975508 A NO 975508A NO 975508 A NO975508 A NO 975508A NO 975508 L NO975508 L NO 975508L
Authority
NO
Norway
Prior art keywords
breast
dna sequence
breast cancer
encoded
mammaglobin
Prior art date
Application number
NO975508A
Other languages
English (en)
Other versions
NO975508D0 (no
Inventor
Mark A Watson
Thimothy P Fleming
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of NO975508D0 publication Critical patent/NO975508D0/no
Publication of NO975508L publication Critical patent/NO975508L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO975508A 1995-05-31 1997-11-28 DNA-sekvens og kodet bryst- spesifikt brystkreftprotein NO975508L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/455,896 US5668267A (en) 1995-05-31 1995-05-31 Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
PCT/US1996/008235 WO1996038463A1 (en) 1995-05-31 1996-05-31 Dna sequence and encoded mammary-specific breast cancer protein

Publications (2)

Publication Number Publication Date
NO975508D0 NO975508D0 (no) 1997-11-28
NO975508L true NO975508L (no) 1998-03-18

Family

ID=23810680

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975508A NO975508L (no) 1995-05-31 1997-11-28 DNA-sekvens og kodet bryst- spesifikt brystkreftprotein

Country Status (22)

Country Link
US (5) US5668267A (no)
EP (1) EP0833834B1 (no)
JP (2) JP3949165B2 (no)
KR (1) KR19990022122A (no)
CN (1) CN1279051C (no)
AT (1) ATE190313T1 (no)
AU (1) AU698823B2 (no)
BR (1) BR9609270A (no)
CA (2) CA2741641C (no)
CZ (1) CZ378397A3 (no)
DE (1) DE69607001T2 (no)
DK (1) DK0833834T3 (no)
EA (1) EA001398B1 (no)
ES (1) ES2145451T3 (no)
GR (1) GR3033636T3 (no)
HU (1) HUP9900873A3 (no)
NO (1) NO975508L (no)
NZ (1) NZ309445A (no)
PL (1) PL323632A1 (no)
PT (1) PT833834E (no)
TR (1) TR199701462T1 (no)
WO (1) WO1996038463A1 (no)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566072B1 (en) * 1995-05-31 2003-05-20 Washington University Mammaglobin, a secreted mammary-specific breast cancer protein
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6344550B1 (en) 1996-01-11 2002-02-05 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6225054B1 (en) 1996-01-11 2001-05-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6423496B1 (en) 1996-01-11 2002-07-23 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
EP0896614A4 (en) * 1996-03-21 1999-05-12 Human Genome Sciences Inc HUMANE, ENDOMETRIUM-SPECIFIC STEROID-BINDING FACTORS I, II AND III
US6174992B1 (en) 1997-03-21 2001-01-16 Human Genome Sciences, Inc. Human endometrial specific steroid-binding factor I, II and III
US6770435B1 (en) 1996-08-19 2004-08-03 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
WO1998007753A1 (en) * 1996-08-19 1998-02-26 Abbott Laboratories Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
US7282207B1 (en) 1996-08-19 2007-10-16 Abbott Laboratories Reagents and methods useful for detecting diseases of the reproductive tissues
US20030044859A1 (en) * 1996-08-19 2003-03-06 Henslee Jerry G. Reagents and methods useful for detecting diseases of the breast
US6379671B1 (en) * 1996-08-19 2002-04-30 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US6552164B1 (en) 1996-08-19 2003-04-22 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
CA2270156A1 (en) * 1996-11-12 1998-05-22 Incyte Pharmaceuticals, Inc. Human breast tumor-specific proteins
ZA982968B (en) * 1997-04-09 1998-10-27 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
DE69830169T2 (de) 1997-06-09 2006-02-16 Smithkline Beecham Corp. Nachweis und behandlung von krebs
JP2003521216A (ja) * 1997-08-05 2003-07-15 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ９０個のヒト分泌タンパク質
JP2001520015A (ja) * 1997-10-16 2001-10-30 インサイト・ファーマスーティカルズ・インコーポレイテッド ヒト・マンモグロビンホモログ
WO1999025877A1 (en) * 1997-11-18 1999-05-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US20040033230A1 (en) * 1997-12-24 2004-02-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
EP1042506A1 (en) * 1997-12-26 2000-10-11 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
WO1999037775A2 (en) * 1998-01-26 1999-07-29 Genquest, Inc. Compositions and methods for detecting and treating breast cancer
DE19813839A1 (de) * 1998-03-20 1999-09-23 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Brusttumorgewebe
US6737040B1 (en) 1998-08-04 2004-05-18 Diadexus, Inc. Method and antibody for imaging breast cancer
US6730477B1 (en) * 1998-08-04 2004-05-04 Diadexus, Inc. Method of diagnosing, monitoring and staging breast cancer
WO2000008210A1 (en) * 1998-08-04 2000-02-17 Diadexus Llc A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
US7014996B1 (en) 1998-10-02 2006-03-21 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
EP1169066A4 (en) * 1998-10-02 2002-10-30 Diadexus Inc METHOD FOR DIAGNOSTICS, MONITORING, STAGE DETECTION, IMAGING AND TREATMENT OF GYNAECOLOGICAL CANCER
US7598226B2 (en) * 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6969518B2 (en) * 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6958361B2 (en) * 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6517513B1 (en) 1999-01-21 2003-02-11 Neomatrix, Llc Intraductal breast fluid aspiration device
CA2375049A1 (en) * 1999-05-28 2000-12-07 Corixa Corporation Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
US20030045468A1 (en) * 1999-05-28 2003-03-06 Corixa Corporation Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
US6416956B1 (en) 1999-08-13 2002-07-09 George Washington University Transcription factor, BP1
US20040018570A1 (en) * 1999-09-01 2004-01-29 Brown University Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth
AU1807401A (en) * 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
EP1399584A2 (en) * 2000-10-11 2004-03-24 Avalon Pharmaceuticals Cancer-linked genes as targets for chemotherapy
PL211151B1 (pl) 2000-10-18 2012-04-30 Glaxosmithkline Biolog Sa Kompozycja immunogenna oraz zastosowanie połączenia saponiny, oligonukleotydu immunostymulującego i lipopolisacharydu
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
US6866994B2 (en) * 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
US20030073951A1 (en) * 2001-05-30 2003-04-17 Morton Kevin B. Disposable patient interface for intraductal fluid aspiration system
AU2003217954A1 (en) * 2002-03-06 2003-09-22 Johns Hopkins University Use of biomarkers to detect breast cancer
US20050186577A1 (en) * 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
WO2005084254A2 (en) * 2004-02-27 2005-09-15 Musc Foundation For Research Development Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription
CA2623775A1 (en) 2005-09-19 2007-03-29 Veridex, Llc Methods and materials for identifying the origin of a carcinoma of unknown primary origin
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
EP2491116A4 (en) * 2009-10-22 2013-12-11 Univ Jefferson CELL-BASED ANTI-RISK COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE
CN101974088B (zh) * 2010-11-03 2014-04-02 中国人民解放军军事医学科学院基础医学研究所 乳腺珠蛋白单克隆抗体及其在乳腺癌诊断中的应用
US8790400B2 (en) 2012-06-13 2014-07-29 Elwha Llc Breast implant with covering and analyte sensors responsive to external power source
US8795359B2 (en) 2012-06-13 2014-08-05 Elwha Llc Breast implant with regionalized analyte sensors and internal power source
US8808373B2 (en) 2012-06-13 2014-08-19 Elwha Llc Breast implant with regionalized analyte sensors responsive to external power source
US9144488B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with analyte sensors responsive to external power source
US9211185B2 (en) 2012-06-13 2015-12-15 Elwha Llc Breast implant with analyte sensors and internal power source
US9144489B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with covering, analyte sensors and internal power source
KR102433983B1 (ko) * 2020-02-27 2022-08-23 주식회사 베르티스 암의 진단용 조성물
KR102499678B1 (ko) * 2020-02-27 2023-02-15 주식회사 베르티스 암의 진단용 조성물
WO2021172923A1 (ko) * 2020-02-27 2021-09-02 ㈜베르티스 암의 진단용 조성물
KR102499664B1 (ko) * 2020-02-27 2023-02-15 주식회사 베르티스 암의 진단용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298399A (en) * 1990-08-10 1994-03-29 Sapporo Breweries Limited Gene and process for producing a thermostable urease
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5610031A (en) 1993-10-27 1997-03-11 The General Hospital Corporation B1k chain of laminin and methods of use
US5573916A (en) 1994-05-19 1996-11-12 Coretech, Inc. Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
US5668267A (en) 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens

Also Published As

Publication number Publication date
NZ309445A (en) 1999-11-29
ES2145451T3 (es) 2000-07-01
HUP9900873A2 (hu) 1999-07-28
ATE190313T1 (de) 2000-03-15
HUP9900873A3 (en) 1999-11-29
GR3033636T3 (en) 2000-10-31
PL323632A1 (en) 1998-04-14
EP0833834A1 (en) 1998-04-08
CZ378397A3 (cs) 1998-06-17
CN1189836A (zh) 1998-08-05
JP2007145855A (ja) 2007-06-14
EP0833834B1 (en) 2000-03-08
EA199700447A1 (ru) 1998-08-27
CN1279051C (zh) 2006-10-11
EA001398B1 (ru) 2001-02-26
MX9709364A (es) 1998-08-30
US6677428B1 (en) 2004-01-13
NO975508D0 (no) 1997-11-28
DE69607001T2 (de) 2000-11-02
CA2222747A1 (en) 1996-12-05
CA2222747C (en) 2011-06-28
US5855889A (en) 1999-01-05
CA2741641A1 (en) 1996-12-05
TR199701462T1 (xx) 1998-04-21
EP0833834A4 (en) 1998-06-03
CA2741641C (en) 2014-08-05
BR9609270A (pt) 1999-05-11
US5968754A (en) 1999-10-19
DE69607001D1 (de) 2000-04-13
US6004756A (en) 1999-12-21
JPH11507212A (ja) 1999-06-29
AU698823B2 (en) 1998-11-05
US5668267A (en) 1997-09-16
WO1996038463A1 (en) 1996-12-05
PT833834E (pt) 2000-08-31
KR19990022122A (ko) 1999-03-25
AU5961696A (en) 1996-12-18
JP3989528B2 (ja) 2007-10-10
DK0833834T3 (da) 2000-07-31
JP3949165B2 (ja) 2007-07-25

Similar Documents

Publication Publication Date Title
NO975508D0 (no) DNA-sekvens og kodet bryst- spesifikk brystkreftprotein
TR200003685T1 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin
AU1726199A (en) Metastatic cancer regulated gene
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
DK0612350T3 (da) Ubiquitin-specifikke proteaser
MX9708791A (es) Gen de ataxia-telangiectasia y su organizacion genomica.
WO2000050588A3 (en) Genes associated with diseases of the colon
ES2166822T3 (es) Procedimientos de seleccion de la enfermedad de crohn usando alelos de microsatelites de tnf.
AU8727201A (en) Genes involved in intestinal inflammatory diseases and use thereof
NO20011394L (no) Mammoglobin, et sekrert brystspesifikt brystkreftprotein
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
DE60025704D1 (de) Das goodpasture-antigen bindende protein
TR200501541T2 (tr) Leu-hirudinin e.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları
WO2005019475A3 (en) Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc)
EA199900256A1 (ru) Нуклеотидная и белковая последовательность маммастатина и способы применения
NO20020329D0 (no) Antitumor antistoffer, proteiner og anvendelser derav
NO20011961D0 (no) PRV-1-genet og anvendelsen av dette
PT1045914E (pt) Proteinase svph1-8 humana especifica de testiculo
DE60134956D1 (de) Gene differentiell experimiert in brudtkrebs
WO2003060074A3 (en) Novel metastasis suppressor gene on human chromosome 8

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application